This week, on the precipice of a historic U.S. election I will start with a brief commentary on making portfolio decisions based on election outcomes.
Back by popular demand we have decided to make our new Case For, Case Against segment a permanent fixture. Our head of income research, Mr. Aaron Dunn will make his highly anticipated first argument facing off against Brennan. In the line of fire is Apple Inc. (AAPL: NASDAQ), the iPhone company which should need no introduction. While the stock sold off this week after its quarterly results included a lack of forward guidance, the consumer tech giant is up 47% this year. We argue both sides of the BUY/SELL argument for the stock.
With a hat tip to Movember and men’s cancer prevention and treatment, this week’s Your Stock, Our Take was sent in from a listener on Profound Medical Corp. (PRN: TSX), a medical technology company developing medical treatments with its core technology used to ablate the prostate gland. We let you know if the share price gains are justifiable based on the underlying cash flow at present.
Stock Talk Podcast Episode 235
Stock Talk Podcast Episode 234
Stock Talk Podcast Episode 233
Stock Talk Podcast Episode 232
Stock Talk Podcast Episode 231
Stock Talk Podcast Episode 230
Stock Talk Podcast Episode 229
Stock Talk Podcast Episode 228
Stock Talk Podcast Episode 227
Stock Talk Podcast Episode 226
Stock Talk Podcast Episode 225
Stock Talk Podcast Episode 224
Stock Talk Podcast Episode 223
Stock Talk Podcast Episode 222
Stock Talk Podcast Episode 221
Stock Talk Podcast Episode 220
Stock Talk Podcast Episode 219
Stock Talk Podcast Episode 218
Stock Talk Podcast Episode 217
Stock Talk Podcast Episode 216
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast